Literature DB >> 31392133

Role of heat shock proteins in bladder cancer: potential biomarkers for treatment response and oncological prognosis.

Jorge Daza1, Zeynep Gul1, John P Sfakianos1.   

Abstract

Entities:  

Year:  2019        PMID： 31392133      PMCID： PMC6642981          DOI： 10.21037/tau.2019.01.11

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN： 2223-4683


× No keyword cloud information.
  10 in total

1.  Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro.

Authors:  Li-Hong Lv; Yun-Le Wan; Yan Lin; Wei Zhang; Mei Yang; Guo-Lin Li; Hao-Ming Lin; Chang-Zhen Shang; Ya-Jin Chen; Jun Min
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

2.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

Authors:  Marko Babjuk; Andreas Böhle; Maximilian Burger; Otakar Capoun; Daniel Cohen; Eva M Compérat; Virginia Hernández; Eero Kaasinen; Joan Palou; Morgan Rouprêt; Bas W G van Rhijn; Shahrokh F Shariat; Viktor Soukup; Richard J Sylvester; Richard Zigeuner
Journal:  Eur Urol       Date:  2016-06-17       Impact factor: 20.096

3.  Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

Authors:  Richard J Sylvester; Adrian P M van der Meijden; Willem Oosterlinck; J Alfred Witjes; Christian Bouffioux; Louis Denis; Donald W W Newling; Karlheinz Kurth
Journal:  Eur Urol       Date:  2006-01-17       Impact factor: 20.096

Review 4.  The role of heat shock proteins in bladder cancer.

Authors:  Joseph Ischia; Alan I So
Journal:  Nat Rev Urol       Date:  2013-05-14       Impact factor: 14.432

5.  EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin.

Authors:  Samantha Cambier; Richard J Sylvester; Laurence Collette; Paolo Gontero; Maurizio A Brausi; George van Andel; Wim J Kirkels; Fernando Calais Da Silva; Willem Oosterlinck; Stephen Prescott; Ziya Kirkali; Philip H Powell; Theo M de Reijke; Levent Turkeri; Sandra Collette; Jorg Oddens
Journal:  Eur Urol       Date:  2015-07-23       Impact factor: 20.096

6.  Clinical significance of heat shock protein-70 expression in bladder cancer.

Authors:  Konstantinos N Syrigos; Kevin J Harrington; Anastasios J Karayiannakis; Eleutheria Sekara; Emmy Chatziyianni; Ekaterini I Syrigou; Jonathan Waxman
Journal:  Urology       Date:  2003-03       Impact factor: 2.649

7.  Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion.

Authors:  Manoj Garg; Deepika Kanojia; Amlesh Seth; Rajive Kumar; Anju Gupta; Avadhesha Surolia; Anil Suri
Journal:  Eur J Cancer       Date:  2010-01       Impact factor: 9.162

8.  Heat shock proteins 60 and 70 are associated with long-term outcome of T1-stage high-grade urothelial tumors of the bladder treated with intravesical Bacillus Calmette-Guérin immunotherapy.

Authors:  Roy Mano; Sofia Zilber; Renzo G Di Natale; Daniel Kedar; David A Lifshitz; Ofer Yossepowitch; Jack Baniel; David Margel
Journal:  Urol Oncol       Date:  2018-10-15       Impact factor: 3.498

Review 9.  Heat Shock Protein-Peptide and HSP-Based Immunotherapies for the Treatment of Cancer.

Authors:  Maxim Shevtsov; Gabriele Multhoff
Journal:  Front Immunol       Date:  2016-04-29       Impact factor: 7.561

10.  HSP70-based anti-cancer immunotherapy.

Authors:  Irina V Guzhova; Boris A Margulis
Journal:  Hum Vaccin Immunother       Date:  2016-06-13       Impact factor: 3.452
  10 in total
  1 in total

1.  Effect of silver nanoparticles on gene transcription of land snail Helix aspersa.

Authors:  Faten Turki; Ridha Ben Younes; Mohsen Sakly; Khemais Ben Rhouma; José-Luis Martinez-Guitarte; Salem Amara
Journal:  Sci Rep       Date:  2022-02-08       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.